Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
26
27
28
29
30
31
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
17
18
20
21
22
24
25
26
27
28
29
30
1
2
3
4
5
6
BARDA Industry Day
2020-10-27    
12:00 am
Organized by BARDA BARDA Industry Day is the annual meeting held to increase potential partner’s awareness of U.S. Government medical countermeasure priorities, interact with BARDA [...]
The Future of Insurance USA
2020-11-16 - 2020-11-18    
All Day
We’re excited to announce today the launch of The Future of Insurance USA (November 16-18 2020), an online 3-day conference by Reuters Events. The Future [...]
Geneva Health Forum 2020
2020-11-16 - 2020-11-18    
12:00 am
Geneva Health Forum 2020 The 8th edition of the Geneva Health Forum will take place from 16-18 November 2020. The thematic of the year will [...]
19 Nov
2020-11-19 - 2020-11-20    
12:00 am
The stage is set for a paradigm shift in healthcare. The opportunity exists to redefine healthcare in a way that transforms patient outcomes, drives efficiency [...]
The 2nd Saudi International Pharma Expo
2020-11-23 - 2020-11-24    
All Day
ABOUT THE 2ND SAUDI INTERNATIONAL PHARMA EXPO SAUDI INTERNATIONAL PHARMA EXPO offers you an EXCELLENT opportunity to expand your business in Saudi Arabia and international [...]
World Congress on Medical Toxicology
2020-12-01 - 2020-12-02    
12:00 am
World Congress on Medical Toxicology Medical Toxicology Pharma 2020 provides a global platform to meet and develop interpersonal relationship with the world’s leading toxicologists, pharmacologists, [...]
01 Dec
2020-12-01 - 2020-12-02    
All Day
International Conference on Food Technology & Beverages” at Kyoto, Japan in the course of Kyoto, Japan, December, 01-02, 2020 Theme of the Food Tech 2020 [...]
Biomedical, Bio Pharma and Clinical Research
2020-12-03 - 2020-12-04    
12:00 am
Biomedical, Bio Pharma and Clinical Research Conference Series LLC LTD cordially invites you to be a part of “2nd International Conference on Biomedical, Bio Pharma [...]
Events on 2020-10-27
BARDA Industry Day
27 Oct 20
Events on 2020-11-16
Events on 2020-11-19
Events on 2020-11-23
The 2nd Saudi International Pharma Expo
23 Nov 20
King Abdullah
Events on 2020-12-03
Latest News

Apr 19: Lack of Interoperability Limits Meaningful Use Program

healthcare information exchange

Meaningful use stages 1 and 2 fall short of implementing the interoperability among electronic health records that is necessary to facilitate information exchange and develop a robust health data infrastructure, according to a new report from a taskforce assembled by the MITRE Corporation, Health Data Management reports.

Under the 2009 federal economic stimulus package, health care providers who demonstrate meaningful use of EHR systems can qualify for Medicaid and Medicare incentive payments (Slabodkin, Health Data Management, 4/17).

Details of Report

HHS released the report, which was developed by JASON, an independent taskforce that advises the federal government on issues pertaining to science and technology (DeSalvo, “Health IT Buzz,” 4/16). The report was funded by the Agency for Healthcare Research and Quality.

In the report, the taskforce concluded that the criteria for meaningful use stages 1 and 2 “fall short of achieving meaningful use in any practical sense,” adding that “large-scale interoperability amounts to little more than replacing fax machines with the electronic delivery of page-formatted medical records.”

According to the taskforce, “most patients still cannot gain electronic access to their health information,” and “rational access to EHRs for clinical care and biomedical research does not exist outside the boundaries of individual organizations.”

Recommendations

The authors recommend that CMS “embrace Stage 3 meaningful use as an opportunity to break free from the status quo and embark upon the creation of a truly interoperable health data infrastructure” (Health Data Management, 4/17).

In addition, they recommend that the Office of the National Coordinator for Health IT:

  • Develop “overarching software architecture for health data infrastructure” within 12 months;
  • Ensure that Stage 3 objectives be defined in such a way that they “enable the creation of an entrepreneurial space across the entire health data enterprise”;
  • Solicit input from the biomedical research sector to ensure that the data infrastructure “meets the needs of researchers”;
  • Ensure that the software architecture is flexible enough to accommodate new data types, has the capacity to expand and is able to balance “the privacy implications of new data types with the societal benefits of biomedical research”;
  • Lead efforts to ensure international interoperability in order to facilitate research; and
  • Employ large-scale data mining techniques and predictive analyses to detect fraud (JASON report, 4/9).

Reaction

National Coordinator for Health IT Karen DeSalvo in a blog post said that the report was a “comprehensive and thoughtful look at the technical challenges in our health [IT] system” (Health Data Management, 4/17).

DeSalvo added that CMS has “already begun to work on many of the recommendations cited in the report,” although she acknowledged that “this represents the beginning, not the end of our efforts.” She said that the agency likely will prioritize “meaningful interoperability” as it moves to “build a national consensus agenda on health IT” (“Health IT Buzz,” 4/16). Source